KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors, today announced Maxine Gowen, Ph.D., its chief executive officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Thursday November 19, 2015 at 3:20 p.m. GMT (10:20 a.m. EST) in London.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
